ALYATEC

Nous participerons à l'évènement « Pagode Ouverte » le 17 décembre prochain au campus Nextmed Strasbourg. Cette journée organisée par BioValley France sera l’occasion de présenter notre expertise clinique et d’échanger avec les entreprises innovantes de l’écosystème #santé de l’Eurométropole de Strasbourg. We will participate in the event “Pagode Ouverte” on 17th December at the Nextmed Strasbourg campus. This event organized by BioValley France will be an opportunity to present our clinical expertise and exchange with innovative companies from the #health ecosystem of Strasbourg territory. https://lnkd.in/dMSYTwkB

Results of RHINIL-2 clinical study carried out by ALYATEC are now published in JACI ! 24 patients were exposed in ALYATEC allergen exposure chamber to evaluate low-dose IL-2 treatment for birch pollen allergy. Check out the publication: https://lnkd.in/dGGtqNfy Thanks to AP-HP, Assistance Publique - Hôpitaux de Paris team for your confidence in ALYATEC ! Michelle Rosenzwajg Roberta Lorenzon David Klatzmann

Many thanks to Hippo Dx for entrusting us with the conduct of a clinical study involving the S.P.A.T device. We are delighted to start this new collaboration !

ALYATEC enrolled participants and collected clinical data for the CATS study. The clinical results have been released in Clinical and Translational Allergy Journal : https://lnkd.in/df_bEruG

We are present at the 2024 annual congress of the European Respiratory Society in Vienna (7-11 Sept). Poster presentation and business meetings are planned. Happy to exchange with the community for this major event ! More information on: https://lnkd.in/dWng7gC

We are proud to get an award for an outstanding poster presentation at the 2024 European Academy of Allergy and Clinical Immunology - EAACI congress in Valencia - Spain. More information available on our website about this prize dealing with the technical evaluation of Airsonett AB Air4 medical device : https://lnkd.in/dGG-aj43

Look at the latest findings of our partner Airsonett AB, evaluating the efficacy of TLA technology in reducing airborne allergen. We are very pleased to have conducted this study in ALYATEC facilities. The results were presented last week at the 2024 congress of the European Academy of Allergy and Clinical Immunology - EAACI. We are looking forward to continue our collaboration with this promising company ! https://lnkd.in/dpB2RPPW

Many thanks to everyone we met at the European Academy of Allergy and Clinical Immunology - EAACI congress for your interest in ALYATEC activities and the successfull discussions we had. See you next year in Glasgow !

We will be present at the 2024 European Academy of Allergy and Clinical Immunology - EAACI congress in Valencia (ESP) from 31 May to 3 June. You can meet us during the following sessions: FT 02 - Flash talks on Asthma (8.30-10.00, 31 May) Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber. TPS27 - Prevention (12.00-13.00, 31 May) Evaluation of temperature-controlled laminar airflow technology to filter aeroallergen-contaminated ambient air in environmental exposure chamber. #EAACIcongress

Today we hosted a delegation of 30 German allergists and physicians in ALYATEC facilities. Thanks to STALLERGENES GREER for organizing this seminar in Strasbourg. It was a pleasure to introduce our clinical activities related to the allergen exposure chamber. Bis bald !